When algorithms can analyze an embryo and recommend which should be fertilized, will sex as we know it become an outdated, analog technology? Could data and wearable sensors transform the way we conceive? Join us for the first Creation event of our 2019 LifeCycle series as we examine thought-provoking questions about how technology will transform ideas about sexual reproduction.
Already, advances in genetics technology have created incredible opportunities for parents who might otherwise be unable to conceive. But as advancements offer greater control — even veering toward “optimization” — of tomorrow’s children, we face new ethical, legal, and moral questions.
We welcome Henry Greely, Director, Stanford University Center for Law and the Biosciences and the author of “The End of Sex and the Future of Human Reproduction;“ Jyotsana Saha, Head of Growth at Future Family; and Lea von Bidder, Co-Founder and CEO of Ava Science, Inc., which creates wearable sensors for fertility tracking in women.
6:30pm — doors open
7:00pm — talks and discussion
8:00pm — networking
9:00pm — doors close
Henry T. Greely specializes in the ethical, legal, and social implications of new biomedical technologies, particularly those related to neuroscience, genetics, or stem cell research. He frequently serves as an advisor on California, national, and international policy issues. He is chair of California’s Human Stem Cell Research Advisory Committee, a member of the Advisory Council of the NIH’s National Institute for General Medical Sciences, a member of the Committee on Science, Technology, and Law of the National Academies, a member of the Neuroscience Forum of the Institute of Medicine, and served from 2007-2010 as co-director of the Law and Neuroscience Project, funded by the MacArthur Foundation. Professor Greely chairs the steering committee for the Stanford Center for Biomedical Ethics and directs both the law school’s Center for Law and the Biosciences and the Stanford Program in Neuroscience and Society. In 2007 Professor Greely was elected a fellow of the American Association for the Advancement of Science.
Jyotsana Saha is the Head of Growth at Future Family, a fintech company for fertility care, providing financing and personalized fertility care services to women and couples, and innovating affordable subscription plans for IVF and egg freezing. Her interest in healthcare stems from her work across North America and Africa, and her parents’ pediatric clinic in India. She believes access to healthcare builds resilient communities.
Lea von Bidder
Lea von Bidder is the Co-Founder and CEO of Ava Science, Inc. Prior to joining Ava, for which she also serves as Vice President of Marketing, Lea co-founded L’inouï, a premium chocolate production and retail chain in Bangalore, India. She also spent time working for the marketing division of Procter & Gamble in Frankfurt and for a strategy-consulting boutique in Paris. Lea holds a Master’s degree in global entrepreneurship from EM Lyon in France, Zhejiang University in China and Purdue Krannert University in the USA. She earned her Bachelor’s degree from the University of St.Gallen and HEC Montréal in Canada.
Throughout 2019, swissnex San Francisco will bring together experts from a wide range of disciplines to explore the questions we confront in an age of CRISPR, genetics, the datafication of DNA, artificial intelligence, and synthetic biology. Connecting artists and scientists, we’ll pose challenging questions about where we want our tech to take us: not only looking at what is possible today, but how to be responsible stewards of our new health tech revolution.